Hormonal Disruptions and Pituitary Tumors

An endocrinologist in India discusses the hormonal disruption experienced by pituitary patients. Read more: https://www.hindustantimes.com/lifestyle/health/hormonal-disruptions-caused-by-pituitary-tumours-endocrinologist-shares-insights-101718974544057.html

Novel Cushing’s Treatment in Phase 2 Trials

The pharmaceutical company Lundbeck  is now in Phase 2 clinical trials to assess a “potential first-in-class” treatment for Cushing’s disease called LuAG13909. Read more:

https://cushingsdiseasenews.com/news/possible-first-in-class-cushings-disease-treatment-being-tested-phase-2-trial/

Pain in Men vs Women: The Role of Hormones

An article in Very Well Health looks at a study on how pain is produced and felt in women versus men. The researchers found that the hormone prolactin lowered the threshold to activate specialized sensory cells called nociceptors in female cells but did not in male cells.   However the neuropeptide  orexin B had the opposite effect. This could have implications for pain management, as women make up a large percentage of patients seeking treatment for pain. Read more:

https://www.verywellhealth.com/women-and-men-have-differences-in-pain-production-8665947

Hormonal Disruptions and Pituitary Tumors

An endocrinologist in India discusses the hormonal disruption experienced by pituitary patients. Read more: https://www.hindustantimes.com/lifestyle/health/hormonal-disruptions-caused-by-pituitary-tumours-endocrinologist-shares-insights-101718974544057.html